Back
CRISPR Therapeutics AG Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CRSP
CRISPR Therapeutics AG
Last Price:
48.19
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.15 | Buy |
| 20-day SMA: | 47.25 | Buy |
| 50-day SMA: | 50.65 | Sell |
| 200-day SMA: | 60.65 | Sell |
| 8-day EMA: | 48.26 | Sell |
| 20-day EMA: | 47.95 | Buy |
| 50-day EMA: | 50.07 | Sell |
| 200-day EMA: | 56.19 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 49.65 | Sell |
| Chaikin Money Flow: | -473561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.83 - 49.31) | Buy |
| Bollinger Bands (100): | (48.6 - 58.54) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 48.23 while CRSP 8-day simple moving average is 48.15, which is a Buy signal.
- The stock price of CRSP is 48.23 while CRISPR Therapeutics AG 20-day SMA is 47.25, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 50.65 while CRSP share price is 48.23, making it a Sell technically.
- CRSP stock price is 48.23 and CRISPR Therapeutics AG 200-day simple moving average is 60.65, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
42
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $48.23. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.11B
Price in USD:
48.23
Share Volume:
973.84K
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
37.55
Sell
42
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 48.23 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 48.23 while CRSP 8-day exponential moving average is 48.26, which is a Sell signal.
- The stock price of CRSP is 48.23 while CRISPR Therapeutics AG 20-day EMA is 47.95, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 50.07 while CRSP share price is 48.23, making it a Sell technically.
- CRSP stock price is 48.23 and CRISPR Therapeutics AG 200-day simple moving average is 56.19, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 49.65, which suggest CRISPR Therapeutics AG is oversold
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (45.83 - 49.31), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (48.6 - 58.54), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.